- Having successfully completed parent study B7601003.
- Clinical diagnosis of Parkinson's disease.
- Able to refrain from any Parkinson's disease medication not permitted by the protocol.
- Female of childbearing potential.
- Severe acute or chronic medical or psychiatric condition or laboratory abnormality.
- Participation in other studies involving investigational drug(s), or treatment with
any investigational drug within 30 days.